Breaking Bad? The Uneasy Case for Regulatory Breakeven Analysis
Daniel A. Farber
University of California, Berkeley - School of Law
April 28, 2014
Assessing regulatory benefits is crucial to cost-benefit analysis. And yet, quantification can be problematic, either because of the nature of the benefit themselves or because of uncertainty about achieving them. In such situations, Cass Sunstein calls for the use of a breakeven analysis based on a judgment about whether regulatory benefits are at least as high as costs.
Even assuming that cost-benefit analysis is the best way of making decisions when benefits can be readily quantified, breakeven analysis may or may not be the right approach when quantification is difficult. Instead, depending on the causes of the difficulty, we might want either to revert to more qualitative methods of decision-making or to move beyond breakeven analysis into more rigorous methodologies. Thus, the case for breakeven analysis remains unproven.
Number of Pages in PDF File: 20
Keywords: cost-benefit analysis, unquantifiable benefits, ambiguity, uncertainty
JEL Classification: H43, I18, K23, K32, Q25working papers series
Date posted: April 30, 2014
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo4 in 0.344 seconds